본문 바로가기
KERD
논문KCI 등재

Total Hip Arthroplasty in Patients with Hip Osteoporosis: A Narrative Review

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Osteoporosis and osteopenia can affect patients undergoing arthroplasty of the hip, which is typically recommended for patients with severe osteoarthritis or elderly patients with a femoral neck fracture. Preoperative screening for this type of bone loss could be helpful to patients and prevent poor outcomes due to the rate of underdiagnosis of osteoporosis, which can reach 73% in patients undergoing hip arthroplasty. Complications associated with low bone mineral density include periprosthetic fractures as well as an increased revision rate. Although the benefit of antiresorptive medications postoperatively has been demonstrated, when administered preoperatively, worse outcomes were reported compared to its non-usage. Surgical management is as important as pre-medication. According to general recommendations, cemented implants provide greater benefit in osteoporotic patients. However, when using cementless implants, ribbed stems, straight tapered stems, stems with medial calcar contact, and titanium-composed stems can be used to prevent periprosthetic loss of bone mineral density; however, they should not be placed in a varus position. These stems can also be coated with zoledronate and other products.

Abstract

Osteoporosis and osteopenia can affect patients undergoing arthroplasty of the hip, which is typically recommended for patients with severe osteoarthritis or elderly patients with a femoral neck fracture. Preoperative screening for this type of bone loss could be helpful to patients and prevent poor outcomes due to the rate of underdiagnosis of osteoporosis, which can reach 73% in patients undergoing hip arthroplasty. Complications associated with low bone mineral density include periprosthetic fractures as well as an increased revision rate. Although the benefit of antiresorptive medications postoperatively has been demonstrated, when administered preoperatively, worse outcomes were reported compared to its non-usage. Surgical management is as important as pre-medication. According to general recommendations, cemented implants provide greater benefit in osteoporotic patients. However, when using cementless implants, ribbed stems, straight tapered stems, stems with medial calcar contact, and titanium-composed stems can be used to prevent periprosthetic loss of bone mineral density; however, they should not be placed in a varus position. These stems can also be coated with zoledronate and other products.

참고문헌 (83)

  1. LeBoff MS, "The clinician's guide to prevention and treatment of osteoporosis", Osteoporos Int, 33, pp.2049~2102 (2022)[DOI]
  2. Rashki Kemmak A, "Economic burden of osteoporosis in the world : a systematic review", Med J Islam Repub Iran, 34, pp.154~ (2020)
  3. Im GI, "The relationship between osteoarthritis and osteoporosis", J Bone Miner Metab, 32, pp.101~109 (2014)[DOI]
  4. Long H, "Prevalence trends of sitespecific osteoarthritis from 1990 to 2019 : findings from the Global Burden of Disease Study 2019", Arthritis Rheumatol, 74, pp.1172~1183 (2022)[DOI]
  5. GBD 2019 Diseases, "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019", Lancet, 396, pp.1204~1222 (2020)[DOI]
  6. Petis S, "Surgical approach in primary total hip arthroplasty : anatomy, technique and clinical outcomes", Can J Surg, 58, pp.128~139 (2015)[DOI]
  7. Fingar KR, "Healthcare Cost and Utilization Project (HCUP)statistical briefs" (2014), Agency for Healthcare Research and Quality (US)
  8. Schwartz AM, "Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030", J Arthroplasty, 35(6S), pp.S79~S85 (2020)[DOI]
  9. Montgomery S, "Costeffectiveness of dual-mobility components in patients with displaced femoral neck fractures", Bone Joint J, 103-B, pp.1783~1790 (2021)[DOI]
  10. Della Rocca GJ, "Periprosthetic fractures : epidemiology and future projections", J Orthop Trauma, 25(Suppl 2), pp.S66~S70 (2011)[DOI]
  11. Lingard EA, "The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty", Age Ageing, 39, pp.234~239 (2010)[DOI]
  12. James SJ, "Baseline bone mineral density and boneturnover in preoperative hip and knee arthroplasty patients", Bone Joint Res, 3, pp.14~19 (2014)[DOI]
  13. Watanabe N, "The prevalence and treatment of osteoporosis in patients undergoing total hip arthroplasty and the levels of biochemical markers of bone turnover", Bone Joint Res, 11, pp.873~880 (2022)[DOI]
  14. Patel I, "Epidemiology of total hip arthroplasty : demographics, comorbidities and outcomes", Arthroplasty, 5, pp.2~ (2023)[DOI]
  15. Cummings SR, "Epidemiology and outcomes of osteoporotic fractures", Lancet, 359, pp.1761~1767 (2002)[DOI]
  16. Lane NE, "Epidemiology, etiology, and diagnosis of osteoporosis", Am J Obstet Gynecol, 194(2 Suppl), pp.S3~S11 (2006)[DOI]
  17. Kurtz S, "Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030", J Bone Joint Surg Am, 89, pp.780~785 (2007)[DOI]
  18. Xiao PL, "Prevalence and treatment rate of osteoporosis in patients undergoing total knee and hip arthroplasty : a systematic review and meta-analysis", Arch Osteoporos, 17, pp.16~ (2022)[DOI]
  19. Delsmann MM, "High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty", Osteoporos Int, 32, pp.1661~1668 (2021)[DOI]
  20. Chee A, "A call to"own the bone" : osteoporosis is a predictor for adverse two-year outcomes following total hip and knee arthroplasty", Eur J Orthop Surg Traumatol, 33, pp.2889~2894 (2023)[DOI]
  21. Bottai V, "Total hip replacement in osteoarthritis : the role of bone metabolism and its complications", Clin Cases Miner Bone Metab, 12, pp.247~250 (2015)
  22. Domingues VR, "Prevalence of osteoporosis in patients awaiting total hip arthroplasty", Acta Ortop Bras, 23, pp.34~37 (2015)[DOI]
  23. Bernatz JT, "Osteoporosis is common and undertreated prior to total joint arthroplasty", J Arthroplasty, 34, pp.1347~1353 (2019)[DOI]
  24. Ding X, "Risk factors affecting the incidence of postoperative periprosthetic femoral fracture in primary hip arthroplasty patients : a retrospective study", Am J Transl Res, 15, pp.1374~1385 (2023)
  25. Finnilä S, "Increased migration of uncemented acetabular cups in female total hip arthroplasty patients with low systemic bone mineral density. A 2-year RSA and 8-year radiographic follow-up study of 34patients", Acta Orthop, 87, pp.48~54 (2016)[DOI]
  26. Yong EL, "Menopausal osteoporosis : screening, prevention and treatment", Singapore Med J, 62, pp.159~166 (2021)[DOI]
  27. Agarwal A, "Fracture prediction tools in diabetes", Curr Opin Endocrinol Diabetes Obes, 29, pp.326~332 (2022)[DOI]
  28. Wang Z, "Total joint arthroplasty and osteoporosis : looking beyond the joint to bone health", J Arthroplasty, 37, pp.1719~1725 (2022)[DOI]
  29. Anam AK, "Update on osteoporosis screening and management", Med Clin North Am, 105, pp.1117~1134 (2021)[DOI]
  30. Fan T, "Screening for osteoporosis to prevent fractures", Am Fam Physician, 98, pp.593~594 (2018)
  31. Salari N, "The global prevalence of osteoporosis in the world : a comprehensive systematic review and meta-analysis", J Orthop Surg Res, 16, pp.609~ (2021)[DOI]
  32. Fiedler B, "The effect of reduced bone mineral density on elective total hip arthroplasty outcomes", Arch Orthop Trauma Surg, 143, pp.5993~5999 (2023)[DOI]
  33. Holzer LA, "Evaluation of FRAX in patients with periprosthetic fractures following primary total hip and knee arthroplasty", Sci Rep, 13, pp.7145~ (2023)[DOI]
  34. Zhu W, "Bone density may be a promising predictor for blood loss during total hip arthroplasty", J Clin Med, 11, pp.3951~ (2022)[DOI]
  35. Ross AJ, "The impact of prior fragility fractures on complications after total hip arthroplasty : a propensity score-matched cohort study", Arthroplast Today, 11, pp.41~48 (2021)[DOI]
  36. Alm JJ, "Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty", Acta Orthop, 80, pp.531~537 (2009)[DOI]
  37. Zhou W, "Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis", Osteoporos Int, 30, pp.1581~1589 (2019)[DOI]
  38. Scott DF, "Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty : preliminary results of a prospective randomized trial", J Arthroplasty, 28, pp.671~675 (2013)[DOI]
  39. Gao J, "Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty : a meta-analysis from randomized controlled trails", Int J Surg, 47, pp.116~126 (2017)[DOI]
  40. Liu Y, "Zoledronic acid for periprosthetic bone mineral density changes in patients with osteoporosis after hip arthroplasty-an updated meta-analysis of six randomized controlled trials", Front Med(Lausanne), 8, pp.801282~ (2021)[DOI]
  41. Lee YK, "To withhold or to implement bisphosphonate after cementless hip arthroplasty : a dilemma in elderly hip fracture patients", J Orthop Surg Res, 14, pp.66~ (2019)[DOI]
  42. Friedl G, "The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial", J Bone Joint Surg Am, 91, pp.274~281 (2009)[DOI]
  43. Karachalios TS, "Total hip arthroplasty in patients with osteoporosis", Hip Int, 30, pp.370~379 (2020)[DOI]
  44. Jakobsen T, "Effect of topical alendronate treatment on fixation of implants inserted with bone compaction", Clin Orthop Relat Res, 444, pp.229~234 (2006)[DOI]
  45. Bobyn JD, "Zoledronic acid causes enhancement of bone growth into porous implants", J Bone Joint Surg Br, 87, pp.416~420 (2005)[DOI]
  46. Morita A, "Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up : a randomized controlled trial", J Orthop Surg Res, 15, pp.17~ (2020)[DOI]
  47. Su J, "Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty : a meta-analysis of randomized controlled trials", Medicine(Baltimore), 97, pp.e13346~ (2018)[DOI]
  48. Li Q, "Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty : a meta-analysis", J Orthop Surg Res, 13, pp.144~ (2018)[DOI]
  49. Nakura N, "Denosumab prevented periprosthetic bone resorption better than risedronate after total hip arthroplasty", J Bone Miner Metab, 41, pp.239~247 (2023)[DOI]
  50. Iwamoto N, "The effectiveness of mono or combined osteoporosis drug therapy against bone mineral density loss around femoral implants after total hip arthroplasty", J Bone Miner Metab, 32, pp.539~544 (2014)[DOI]
  51. Kobayashi N, "Teriparatide versus alendronate for the preservation of bone mineral density after total hip arthroplasty-a randomized controlled trial", J Arthroplasty, 31, pp.333~338 (2016)[DOI]
  52. Jeong S, "The effect of preoperative bisphosphonate use on total hip arthroplasty outcomes", J Arthroplasty, 38, pp.2393~2397 (2023)[DOI]
  53. Shi M, "Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty : a meta-analysis of 25randomized controlled trials", Osteoporos Int, 29, pp.1525~1537 (2018)[DOI]
  54. Prieto-Alhambra D, "Oral bisphosphonate use and total knee", hip implant survival : validation of results in an external population-based cohort, 2014, pp.66, 3233~3240
  55. Meek RM, "The risk of peri-prosthetic fracture after primary and revision total hip and knee replacement", J Bone Joint Surg Br, 93, pp.96~101 (2011)[DOI]
  56. Li X, "Construction and evaluation of a nomogram prediction model for periprosthetic fractures after total hip arthroplasty", Zhongguo Gu Shang, 36, pp.1036~1040 (2023)[DOI]
  57. Mears SC, "Subsidence of uncemented stems in osteoporotic and non-osteoporotic cadaveric femora", Proc Inst Mech Eng H, 223, pp.189~194 (2009)[DOI]
  58. Viceconti M, "Primary stability of an anatomical cementless hip stem : a statistical analysis", J Biomech, 39, pp.1169~1179 (2006)[DOI]
  59. Moritz N, "Quality of intertrochanteric cancellous bone as predictor of femoral stem RSA migration in cementless total hip arthroplasty", J Biomech, 44, pp.221~227 (2011)[DOI]
  60. Yang C, "Cemented versus uncemented femoral component total hip arthroplasty in elderly patients with primary osteoporosis : retrospective analysis with 5-year follow-up", J Int Med Res, 47, pp.1610~1619 (2019)[DOI]
  61. Chen XT, "Cemented versus cementless femoral fixation for elective primary total hip arthroplasty : a nationwide analysis of short-term complication and readmission rates", J Clin Med, 12, pp.3945~ (2023)[DOI]
  62. Gavaskar AS, "Cemented or cementless THA in patients over 80 years with fracture neck of femur : a prospective comparative trial", Musculoskelet Surg, 98, pp.205~208 (2014)[DOI]
  63. Lindberg-Larsen M, "Postoperative 30-day complications after cemented", hybrid versus cementless total hip arthroplasty in osteoarthritis patients > 70 years, 2020, pp.91, 286~292
  64. Huang ZY, "Midterm outcomes of cemented stem and subtrochanteric shortening derotational osteotomy in total hip arthroplasty for Crowe IV developmental dysplasia", Orthop Surg, 14, pp.3178~3186 (2022)[DOI]
  65. Rahmy AI, "Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating : a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss", Osteoporos Int, 15, pp.281~289 (2004)[DOI]
  66. Gibbons CE, "Periprosthetic bone mineral density changes with femoral components of differing design philosophy", Int Orthop, 25, pp.89~92 (2001)[DOI]
  67. Sychterz CJ, "The influence of clinical factors on periprosthetic bone remodeling", Clin Orthop Relat Res, (322), pp.285~292 (1996)[DOI]
  68. Peitgen DS, "Periprosthetic bone mineral density around uncemented titanium stems in the second and third decade after total hip arthroplasty : a DXA study after 12, 17 and 21 years", Calcif Tissue Int, 103, pp.372~379 (2018)[DOI]
  69. Wu XD, "Short to midterm follow-up of periprosthetic bone mineral density after total hip arthroplasty with the ribbed anatomic stem", Biomed Res Int, 2019, pp.3085258~ (2019)[DOI]
  70. Sano K, "Changes of bone mineral density after cementless total hip arthroplasty with two different stems", Int Orthop, 32, pp.167~172 (2008)[DOI]
  71. Djebara AE, "Comparison of periprosthetic bone mineral density between two types of short-stems in total hip arthroplasty with a mean follow-up of 4 years", Orthop Traumatol Surg Res, 108, pp.103044~ (2022)[DOI]
  72. Li MG, "Periprosthetic changes in bone mineral density in 5 stem designs 5 years after cemented total hip arthroplasty. No relation to stem migration", J Arthroplasty, 22, pp.689~691 (2007)[DOI]
  73. Liu Y, "Comparison of femoral bone mineral density changes around 3 common designs of cementless stems after total hip arthroplasty-a retrospective cohort study", Orthop Surg, 14, pp.1059~1070 (2022)[DOI]
  74. Fujita M, "The influence of stem alignment on the bone mineral density around the Polarstem following total hip arthroplasty", Arch Orthop Trauma Surg, 143, pp.3621~3627 (2023)[DOI]
  75. Munting E, "Effect of a stemless femoral implant for total hip arthroplasty on the bone mineral density of the proximal femur. A prospective longitudinal study", J Arthroplasty, 12, pp.373~379 (1997)[DOI]
  76. El-Daly I, "Modification of regional bone mineral density due to femoral rasping in cementless proximally fixed total hip arthroplasty", Orthop Traumatol Surg Res, 106, pp.543~550 (2020)[DOI]
  77. Kim YH, "Changes in the bone mineral density in the acetabulum and proximal femur after cementless total hip replacement : alumina-on-alumina versus alumina-on-polyethylene articulation", J Bone Joint Surg Br, 89, pp.174~179 (2007)[DOI]
  78. Pakvis DF, "Cancellous and cortical bone mineral density around an elastic press-fit socket in total hip arthroplasty", Acta Orthop, 87, pp.583~588 (2016)[DOI]
  79. Peter B, "Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats", J Biomed Mater Res A, 76, pp.133~143 (2006)[DOI]
  80. Gao Y, "The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats", Biomaterials, 30, pp.1790~1796 (2009)[DOI]
  81. Sun P, "The calcium phosphate modified titanium implant combined with platelet-rich plasma treatment promotes implant stabilization in an osteoporotic model", J Craniofac Surg, 32, pp.603~608 (2021)[DOI]
  82. Goriainov V, "Human skeletal stem cell response to multiscale topography induced by large area electron beam irradiation surface treatment", Front Bioeng Biotechnol, 6, pp.91~ (2018)[DOI]
  83. Tezuka T, "Influence of hydroxyapatite coating for the prevention of bone mineral density loss and bone metabolism after total hip arthroplasty : assessment using 18F-fluoride positron emission tomography and dual-energy X-ray absorptiometry by randomized controlled trial", Biomed Res Int, 2020, pp.4154290~ (2020)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (9건)